Adicet Bio (ACET) Metrics: History & Chart

Adicet Bio, Inc.(ACET)

Biotechnology · Boston, MA

$6.35-0.12 (-1.85%)

Delayed quote: Oct 6, 2026, 1:59 PM EDT

About Adicet Bio, Inc.

Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The company’s strategy involves engineering gamma delta T cells with chimeric antigen receptors (CARs) and T cell receptor-like antibodies. This advanced modification is designed to achieve more precise targeting of tumors, enhance the body's natural and acquired immune responses against cancer, and provide sustained therapeutic benefits for patients. ADI-001, its most advanced therapeutic candidate, is presently in a Phase I clinical trial for individuals with non-Hodgkin's lymphoma. Additionally, Adicet Bio is developing ADI-002, which is undergoing preclinical investigations for its potential in treating a range of solid tumors. The company is headquartered in Boston, Massachusetts.

Boston, MA

102 employees

www.adicetbio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Chen Schor

View full financials

Third-Party DCF Estimate (FMP)	$2.93
Price Gap vs Third-Party Estimate	-54.68%

7D Total Return	+1.89%
30D Total Return	-32.53%
YTD Total Return	-23.16%
1Y Total Return	-51.54%
3Y Total Return	-69.36%
5Y Total Return	-94.61%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-23.16%
2025	-45.29%
2024	-49.11%
2023	-78.86%
2022	-48.89%
2021	+24.48%
2020

CAGR TTM	-51.37%
CAGR 3Y	-32.58%
CAGR 5Y	-44.24%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	64.57
PE Ratio Avg TTM	111.48
PE Ratio Avg 3Y	111.48
Current VS TTM Avg	-42.08%
Current VS 3Y Avg	-42.08%
Current VS 5Y Avg	-42.08%

All Metrics

ACET Valuation Metrics

ACET Stock Price Metrics

ACET Dividend Metrics

ACET Growth Rate Metrics

ACET Discounted Cash Flow Metrics

ACET Returns By Period

ACET Yearly Returns

ACET Average Annual Returns By Period (CAGR)

ACET Revenue Metrics

ACET PE Ratio Metrics

ACET PS Ratio Metrics

ACET PB Ratio Metrics

ACET Price to Free Cash Flow Ratio Metrics

ACET Debt to Equity Ratio Metrics

ACET PEG Ratio Metrics

ACET FCF Yield

ACET Earnings Yield

ACET EBITDA Yield

ACET OCF Yield

ACET EV/EBIT Ratio Metrics

ACET EV/EBITDA Ratio Metrics

ACET EV/Assets Ratio Metrics

ACET EV/Sales Ratio Metrics

ACET Current Ratio Metrics

ACET Quick Ratio Metrics

ACET ROIC Metrics

ACET Return on Assets Metrics

ACET Return on Equity Metrics

ACET Net Profit Margin Metrics

ACET Gross Profit Margin Metrics

ACET Tax Rate Metrics

PS Ratio	11.22
PS Ratio Avg TTM	15.64
PS Ratio Avg 3Y	27.59
Current VS TTM Avg	-28.26%
Current VS 3Y Avg	-59.33%
Current VS 5Y Avg	-59.33%

PB Ratio	0.58
PB Ratio Avg TTM	0.53
PB Ratio Avg 3Y	0.47
Current VS TTM Avg	+9.07%
Current VS 3Y Avg	+24.66%
Current VS 5Y Avg	-22.71%

PFCF Ratio	57.50
PFCF Ratio Avg TTM	99.28
PFCF Ratio Avg 3Y	99.28
Current VS TTM Avg	-42.08%
Current VS 3Y Avg	-42.08%
Current VS 5Y Avg	-42.08%

Debt/Equity Ratio	0.11
Debt/Equity Ratio Avg TTM	0.11
Debt/Equity Ratio Avg 3Y	0.10
Current VS TTM Avg	-3.83%
Current VS 3Y Avg	+8.68%
Current VS 5Y Avg	+18.49%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	1.74%
FCF Yield Avg TTM	0.99%
FCF Yield Avg 3Y	0.99%
Current VS TTM Avg	+76.58%
Current VS 3Y Avg	+76.58%
Current VS 5Y Avg	+76.58%

Earnings Yield	1.55%
Earnings Yield Avg TTM	0.88%
Earnings Yield Avg 3Y	0.88%
Current VS TTM Avg	+76.86%
Current VS 3Y Avg	+76.86%
Current VS 5Y Avg	+76.86%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.33
Ev/Assets Ratio Avg TTM	0.31
Ev/Assets Ratio Avg 3Y	0.26
Current VS TTM Avg	+6.06%
Current VS 3Y Avg	+26.23%
Current VS 5Y Avg	-36.18%

Ev/Sales Ratio	1.75
Ev/Sales Ratio Avg TTM	8.16
Ev/Sales Ratio Avg 3Y	15.41
Current VS TTM Avg	-78.56%
Current VS 3Y Avg	-88.65%
Current VS 5Y Avg	-88.84%

Current Ratio	6.71
Current Ratio Avg TTM	6.99
Current Ratio Avg 3Y	9.25
Current VS TTM Avg	-4.00%
Current VS 3Y Avg	-27.44%
Current VS 5Y Avg	-38.08%

Quick Ratio	6.71
Quick Ratio Avg TTM	6.99
Quick Ratio Avg 3Y	9.25
Current VS TTM Avg	-4.00%
Current VS 3Y Avg	-27.44%
Current VS 5Y Avg	-38.08%

ROIC	(79.68%)
ROIC Avg 3Y	(70.32%)
ROIC Avg 5Y	(51.57%)
Current VS 3Y Avg	-13.31%
Current VS 5Y Avg	-54.50%
Current VS 10Y Avg	-64.73%

ROA	(66.80%)
ROA Avg TTM	(16.10%)
ROA Avg 3Y	(14.51%)
Current VS TTM Avg	-314.89%
Current VS 3Y Avg	-360.31%
Current VS 5Y Avg	-500.39%

ROE	(82.38%)
ROE Avg TTM	(85.56%)
ROE Avg 3Y	(72.06%)
Current VS TTM Avg	+3.71%
Current VS 3Y Avg	-14.32%
Current VS 5Y Avg	-55.02%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	23.38%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%
Current VS 10Y Avg	-100.00%